Clearmind Medicine Inc. - Common Shares, no par value per share (CMND) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2023 to Q3 2025

Type / Class
Equity / Common Shares, no par value per share
Symbol
CMND on Nasdaq
Shares outstanding
59,983,922
Price per share
$0.07
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
281,131
Total reported value
$288,305
% of total 13F portfolios
0%
Share change
+36,232
Value change
+$41,508
Number of holders
7
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Clearmind Medicine Inc. - Common Shares, no par value per share (CMND) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
L.I.A. Pure Capital Ltd 10% -0.2% $2,093,139 +$935,587 5,980,397 +81% L.I.A. Pure Capital Ltd. 03 Dec 2025
Capitalink Ltd. 10% -0.2% $2,093,139 +$935,587 5,980,397 +81% Capitalink Ltd. 03 Dec 2025
Daniel Nissim 10% $3,009,635 3,307,291 Nissim Daniel 19 Nov 2025
Iroquois Capital Management, LLC 9.9% +62% $549,158 +$138,124 603,470 +34% Richard Abbe 30 Sep 2025
AdvisorShares Trust 4.8% $177,102 205,933 AdvisorShares Trust 30 Jun 2025

As of 30 Sep 2025, 7 institutional investors reported holding 281,131 shares of Clearmind Medicine Inc. - Common Shares, no par value per share (CMND). This represents 0.47% of the company’s total 59,983,922 outstanding shares.

Institutional Holders of Clearmind Medicine Inc. - Common Shares, no par value per share (CMND) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 281,131 $288,305 +$41,508 $1.02 7
2025 Q2 244,330 $216,133 -$13,983 $0.88 7
2025 Q1 601,206 $5,451,442 -$30,388 $1.04 6
2024 Q4 612,804 $5,491,207 -$46,684 $1.38 9
2024 Q3 702,419 $5,494,319 +$5,284,113 $1.22 8
2024 Q2 165,796 $276,008 +$33,327 $1.68 4
2024 Q1 153,477 $175,314 +$69,644 $1.14 4
2023 Q4 92,693 $260,467 +$260,467 $2.81 1